pfk13-Independent Treatment Failure in Four Imported Cases of Plasmodium falciparum Malaria Treated with Artemether-Lumefantrine in the United Kingdom

被引：0

作者：

Sutherland, Colin J. ^{[1
,2
]}

Lansdell, Paul ^{[1
]}

Sanders, Mandy ^{[3
]}

Muwanguzi, Julian ^{[2
]}

van Schalkwyk, Donelly A. ^{[2
]}

Kaur, Harparkash ^{[2
]}

Nolder, Debbie ^{[1
]}

Tucker, Julie ^{[1
]}

Bennett, Hayley M. ^{[3
]}

Otto, Thomas D. ^{[3
]}

Berriman, Matthew ^{[3
]}

Patel, Trupti A. ^{[4
]}

Lynn, Roderick ^{[5
]}

Gkrania-Klotsas, Effrossyni ^{[6
]}

Chiodini, Peter L. ^{[1
,4
]}

机构：

[1] London Sch Hyg & Trop Med, Publ Hlth England Malaria Reference Lab, London, England

[2] London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London, England

[3] Wellcome Trust Sanger Inst, Hinxton, England

[4] Hosp Trop Dis, London, England

[5] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Haematol, Cambridge, England

[6] Cambridge Univ Hosp NHS Fdn Trust, Dept Infect Dis, Addenbrookes Hosp, Cambridge, England

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2017年 / 61卷 / 03期

基金：

英国惠康基金;

关键词：

imported malaria; treatment failure; parasite genotyping; antimalarial agents; drug resistance mechanisms; UNCOMPLICATED MALARIA; ARTEMISININ; RESISTANCE;

D O I：

10.1128/AAC.02382-16

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We present case histories of four patients treated with artemether-lumefantrine for falciparum malaria in UK hospitals in 2015 to 2016. Each subsequently presented with recurrent symptoms and Plasmodium falciparum parasitemia within 6 weeks of treatment with no intervening travel to countries where malaria is endemic. Parasite isolates, all of African origin, harbored variants at some candidate resistance loci. No evidence of pfk13-mediated artemisinin resistance was found. Vigilance for signs of unsatisfactory antimalarial efficacy among imported cases of malaria is recommended.

引用

页数：5

共 44 条

[31] Persistent Submicroscopic Plasmodium falciparum Parasitemia 72 Hours after Treatment with Artemether-Lumefantrine Predicts 42-Day Treatment Failure in Mali and Burkina Faso
Beshir, Khalid B.
Diallo, Nouhoum
Some, Fabrice A.
Sombie, Salif
Zongo, Issaka
Fofana, Bakary
Traore, Aliou
Dama, Souleymane
Bamadio, Amadou
Traore, Oumar B.
Coulibaly, Sam A.
Maurice, Ouattara S.
Diarra, Amidou
Kabore, Jean Moise
Kodio, Aly
Togo, Amadou Hamidou
Dara, Niawanlou
Coulibaly, Moctar
Dao, Francois
Nikiema, Frederic
Compaore, Yves D.
Kabore, Naomie T.
Barry, Nouhoun
Soulama, Issiaka
Sagara, Issaka
Sirima, Sodiomon B.
Ouedraogo, Jean-Bosco
Djimde, Abdoulaye
Sutherland, Colin J.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (08)
[32] Monitoring of efficacy, tolerability and safety of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Lambarene, Gabon: an open-label clinical trial
Adegbite, Bayode R.
Edoa, Jean R.
Honkpehedji, Yabo J.
Zinsou, Frejus J.
Dejon-Agobe, Jean C.
Mbong-Ngwese, Mirabeau
Lotola-Mougueni, Fabrice
Koehne, Erik
Lalremruata, Albert
Kreidenweiss, Andrea
Nguyen, The T.
Kun, Jutta
Agnandji, Selidji T.
Lell, Bertrand
Safiou, Abdou R.
Atome, Fridia A. Obone
Mombo-Ngoma, Ghyslain
Ramharter, Michael
Velavan, Thirumalaisamy P.
Mordmueller, Benjamin
Kremsner, Peter G.
Adegnika, Ayola A.
MALARIA JOURNAL, 2019, 18 (01)
[33] Efficacy and Effectiveness of Artemether-Lumefantrine after Initial and Repeated Treatment in Children < 5 Years of Age with Acute Uncomplicated Plasmodium falciparum Malaria in Rural Tanzania: A Randomized Trial
Ngasala, Billy E.
Malmberg, Maja
Carlsson, Anja M.
Ferreira, Pedro E.
Petzold, Max G.
Blessborn, Daniel
Bergqvist, Yngve
Gil, Jose P.
Premji, Zul
Bjoerkman, Anders
Martensson, Andreas
CLINICAL INFECTIOUS DISEASES, 2011, 52 (07) : 873 - 882
[34] Artemisinin-piperaquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Grande Comore island: an open-label, non-randomised controlled trial
Li, Guoming
Yuan, Yueming
Zheng, Shaoqin
Lu, Chenguang
Li, Mingqiang
Tan, Ruixiang
Zhang, Hongying
Silai, Rahamatou
Liu, Ruimei
Abdallah, Kamal Said
Bacar, Affane
Xu, Qin
Song, Jianping
Wu, Wanting
Deng, Changsheng
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 60 (04)
[35] Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine
Sow, D.
Ndiaye, J-L
Sylla, K.
Ba, M. S.
Tine, R. C. K.
Faye, B.
Pene, M.
Ndiaye, M.
Seek, A.
Lo, A. C.
Abiola, A.
Dieng, Y.
Gaye, O.
MEDECINE ET SANTE TROPICALES, 2016, 26 (01): : 45 - 50
[36] Randomized non-inferiority and safety trial of dihydroartemisin-piperaquine and artesunate-amodiaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Cameroonian children
Nji, Akindeh M.
Ali, Innocent M.
Moyeh, Marcel N.
Ngongang, Eric-Oliver
Ekollo, Aristide M.
Chedjou, Jean-Paul
Ndikum, Valentine N.
Evehe, Marie S.
Froeschl, Guenter
Heumann, Christian
Mansmann, Ulrich
Ogundahunsi, Olumide
Mbacham, Wilfred F.
MALARIA JOURNAL, 2015, 14
[37] A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya
Petra F Mens
Patrick Sawa
Sandra M van Amsterdam
Inge Versteeg
Sabah A Omar
Henk DFH Schallig
Piet A Kager
Malaria Journal, 7
[38] Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors that Affect Treatment Outcomes for P-falciparum Malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine
Venkatesan, Meera
Gadalla, Nahla B.
Stepniewska, Kasia
Dahal, Prabin
Nsanzabana, Christian
Moriera, Clarissa
Price, Ric N.
Martensson, Andreas
Rosenthal, Philip J.
Dorsey, Grant
Sutherland, Colin J.
Guerin, Philippe
Davis, Timothy M. E.
Menard, Didier
Adam, Ishag
Ademowo, George
Arze, Cesar
Baliraine, Frederick N.
Berens-Riha, Nicole
Bjorkman, Anders
Borrmann, Steffen
Checchi, Francesco
Desai, Meghna
Dhorda, Mehul
Djimde, Abdoulaye A.
El-Sayed, Badria B.
Eshetu, Teferi
Eyase, Frederick
Falade, Catherine
Faucher, Jean-Francois
Froberg, Gabrielle
Grivoyannis, Anastasia
Hamour, Sally
Houze, Sandrine
Johnson, Jacob
Kamugisha, Erasmus
Kariuki, Simon
Kiechel, Jean-Rene
Kironde, Fred
Kofoed, Poul-Erik
LeBras, Jacques
Malmberg, Maja
Mwai, Leah
Ngasala, Billy
Nosten, Francois
Nsobya, Samuel L.
Nzila, Alexis
Oguike, Mary
Otienoburu, Sabina Dahlstrom
Ogutu, Bernhards
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2014, 91 (04) : 833 - 843
[39] Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis
Marwa, Karol
Kapesa, Anthony
Baraka, Vito
Konje, Evelyne
Kidenya, Benson
Mukonzo, Jackson
Kamugisha, Erasmus
Swedberg, Gote
PLOS ONE, 2022, 17 (03):
[40] Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia
Schramm, Birgit
Valeh, Parastou
Baudin, Elisabeth
Mazinda, Charles S.
Smith, Richard
Pinoges, Loretxu
Sundaygar, Timothy
Zolia, Yah M.
Jones, Joel J.
Comte, Eric
Bruneel, Arnaud
Branger, Michel
Jullien, Vincent
Carn, Gwenaelle
Kiechel, Jean-Rene
Ashley, Elizabeth A.
Guerin, Philippe J.
MALARIA JOURNAL, 2013, 12

← 1 2 3 4 5 →